Tech Company Financing Transactions
Transcend Medical Funding Round
On 4/2/2014, Transcend Medical raised $22 million in Series C funding from private investors.
Transaction Overview
Company Name
Announced On
4/2/2014
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series C
Investors
Proceeds Purpose
The funds will support completion of the US-based, randomized, controlled COMPASS pivotal trial evaluating the CyPass® Micro-Stent, a next-generation, micro-invasive glaucoma implant, in the largest enrolled glaucoma surgery study to date.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
127 Independence Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Transcend Medical, Inc. is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Walsh
Chief Medical Officer
Sean Ianchulev
VP - Bus. Development
Luke Clauson
VP - Marketing
Bart Beasley
VP - Regulatory Affairs
Ginger Clasby
Browse more venture capital transactions:
Prev: 4/2/2014: NeuMoDx Molecular venture capital transaction
Next: 4/3/2014: GTxcel venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs